Lin Group find BrP@MOL Boosts Photodynamic Therapy and Immune Response
The Wenbin Lin Group have made a signifigant advances in cancer treatment.
According to their latest publication in Angewandte, the team have developed a new therapy using a BrP@MOL nanoscale layer, which enhances the effectiveness of a type of cancer treatment known as photodynamic therapy (PDT). BrP@MOL works by changing the metabolism of cancer cells, improving oxygen levels in tumors, and boosting the body's immune response to fight cancer more effectively.
The results are amazing. The group found the therapy had a reduction in tumor growth by over 90%, achieved a 40% cure rate, and prevented cancer from spreading to the lungs. When combined with another treatment that helps the immune system, tumor growth was reduced by more than 98%, with an 80% cure rate. This innovative approach brings new hope in the fight against cancer.
See their work here.